phenylalanine and ADDH

phenylalanine has been researched along with ADDH in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (23.08)	18.7374
1990's	7 (26.92)	18.2507
2000's	6 (23.08)	29.6817
2010's	4 (15.38)	24.3611
2020's	3 (11.54)	2.80

Authors

Authors	Studies
Amato, G; Arnold, GL; Bilder, DA; Dimmock, D; Grant, ML; Janzen, D; Jurecki, E; Longo, N; Merilainen, M; Nguyen-Driver, M; Waisbren, S	1
Bilder, DA; Dimmock, D; Grant, ML; Jurecki, ER; McCandless, SE; Sanchez-Valle, A; Stahl, SM	1
Alamiri, B; El-Sheshaie, A; Elsori, DH; Naguy, A	1
Burton, B; Feigenbaum, A; Gillis, J; Grant, M; Hendren, R; Lang, W; Merilainen, M; Phillips, J; Prasad, S; Sanchez-Valle, A; Singh, R; Siriwardena, K; Stahl, S; Waisbren, S; Yu, S; Zhang, C	1
Bergwerff, CE; Blom, HJ; Luman, M; Oosterlaan, J	1
Coşkun, T; Dursun, A; Sivri, HS; Tokatlı, A; Yıldız, Y	1
Biernacka, M; Biernacki, M; Jakubowska-Winecka, A; Kowalik, A; Kuśmierska, K; Pohorecka, M; Sykut-Cegielska, J	1
Antshel, KM; Waisbren, SE	2
Ebert, D; Krause, J; Roth-Sackenheim, C	1
Arnold, GL; Blakely, EM; DeLuca, J; Orlowski, CC; Vladutiu, CJ	1
Johnston, MV; Singer, HS	1
Anderson, GM; Gillespie, SM; Shaywitz, BA; Shaywitz, SE; Sullivan, B; Sullivan, CM	1
Ambrose, P; Craft, S; Dowton, SB; Gourovitch, ML; Sparta, S	1
Funders, B; Koch, HG; Pietsch, M; Ullrich, K; Weglage, J	1
Matsuishi, T; Yamashita, Y	1
Boyle, M; Cunningham, C; Jadad, AR; Kim, M; Schachar, R	1
de Sonneville, LM; Huijbregts, SC; Licht, R; Sergeant, JA; van Spronsen, FJ; Verkerk, PH	1
Ashton, SE; Baker, GB; Bornstein, RA; Coutts, RT; Rouget, AC; van Muyden, JC	1
Baker, GB; Bornstein, RA; Carroll, A; Douglass, AB; King, G; Wong, JT	1
Karoum, F; Rapoport, JL; Zametkin, AJ	1
Reimherr, FW; Ward, M; Wender, PH; Wood, DR	1
Chang, PN; Fisch, RO; Garfinkel, BD; Realmuto, GM; Shapiro, S; Tsai, MY; Tuchman, M	1
Reimherr, FW; Wender, PH; Wood, DR	2

Reviews

3 review(s) available for phenylalanine and ADDH

Article	Year
[ADHD in adulthood--guidelines based on expert consensus with DGPPN support]. Der Nervenarzt, 2003, Volume: 74, Issue:10 Topics: Administration, Cutaneous; Administration, Oral; Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Diagnosis, Differential; Evidence-Based Medicine; Germany; Humans; Lithium Carbonate; Nicotine; Patient Care Team; Phenylalanine; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Referral and Consultation	2003
Brain neurotransmitters and neuromodulators in pediatrics. Pediatrics, 1982, Volume: 70, Issue:1 Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Brain; Child; Endorphins; Enkephalins; Epilepsy; Humans; Movement Disorders; Neurotransmitter Agents; Pain; Phenylalanine; Psychotic Disorders; Receptors, Neurotransmitter	1982
Treatment of attention-deficit/hyperactivity disorder. Evidence report/technology assessment (Summary), 1999, Issue:11 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Combined Modality Therapy; Desipramine; Dextroamphetamine; Evidence-Based Medicine; Follow-Up Studies; Humans; Imipramine; Methylphenidate; Nicotine; Nicotinic Agonists; Pemoline; Phenylalanine; Placebos; Randomized Controlled Trials as Topic; Safety; Treatment Outcome	1999

Trials

8 trial(s) available for phenylalanine and ADDH

Article	Year
Neuropsychiatric Function Improvement in Pediatric Patients with Phenylketonuria. The Journal of pediatrics, 2023, Volume: 260 Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cognition; Double-Blind Method; Executive Function; Humans; Infant; Phenylalanine; Phenylketonurias; Treatment Outcome	2023
A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria. Molecular genetics and metabolism, 2015, Volume: 114, Issue:3 Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Biopterins; Child; Dose-Response Relationship, Drug; Double-Blind Method; Executive Function; Female; Humans; Male; Phenylalanine; Phenylketonurias; Young Adult	2015
Aspartame, behavior, and cognitive function in children with attention deficit disorder. Pediatrics, 1994, Volume: 93, Issue:1 Topics: Adolescent; Aspartame; Attention Deficit Disorder with Hyperactivity; Catecholamines; Child; Child Behavior; Child, Preschool; Cognition; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Phenylalanine	1994
Treatment of hyperactive children with D-phenylalanine. The American journal of psychiatry, 1987, Volume: 144, Issue:6 Topics: Aspartame; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Double-Blind Method; Humans; Isomerism; Male; Phenylalanine; Psychiatric Status Rating Scales; Psychomotor Performance	1987
An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type. The American journal of psychiatry, 1987, Volume: 144, Issue:8 Topics: Adult; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Female; Humans; Levodopa; Male; Middle Aged; Phenylalanine; Psychiatric Status Rating Scales; Tyrosine	1987
Psychiatric diagnosis and behavioral characteristics of phenylketonuric children. The Journal of nervous and mental disease, 1986, Volume: 174, Issue:9 Topics: Adjustment Disorders; Adolescent; Adult; Attention; Attention Deficit Disorder with Hyperactivity; Child; Depression; Double-Blind Method; Female; Humans; Male; Phenylalanine; Phenylketonurias; Placebos; Psychiatric Status Rating Scales; Psychological Tests	1986
Amino acid precursors for the treatment of attention deficit disorder, residual type. Psychopharmacology bulletin, 1985, Volume: 21, Issue:1 Topics: Adult; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Phenylalanine; Tyrosine	1985
Treatment of attention deficit disorder with DL-phenylalanine. Psychiatry research, 1985, Volume: 16, Issue:1 Topics: Adult; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Phenylalanine; Time Factors	1985

Other Studies

15 other study(ies) available for phenylalanine and ADDH

Article	Year
Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria. American journal of medical genetics. Part A, 2022, Volume: 188, Issue:3 Topics: Adult; Attention Deficit Disorder with Hyperactivity; Clinical Studies as Topic; Humans; Phenylalanine; Phenylketonurias	2022
Solriamfetol for attention deficit hyperactivity disorder. CNS spectrums, 2022, Volume: 27, Issue:6 Topics: Attention Deficit Disorder with Hyperactivity; Carbamates; Humans; Phenylalanine	2022
No Tryptophan, Tyrosine and Phenylalanine Abnormalities in Children with Attention-Deficit/Hyperactivity Disorder. PloS one, 2016, Volume: 11, Issue:3 Topics: Adolescent; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Case-Control Studies; Child; Conduct Disorder; Diet; Dietary Proteins; Female; Humans; Male; Netherlands; Phenylalanine; Surveys and Questionnaires; Tryptophan; Tyrosine	2016
Late-diagnosed phenylketonuria in an eight-year-old boy with dyslexia and attention-deficit hyperactivity disorder. The Turkish journal of pediatrics, 2016, Volume: 58, Issue:1 Topics: Attention Deficit Disorder with Hyperactivity; Child; Delayed Diagnosis; Diagnosis, Differential; Dyslexia; Humans; Infant, Newborn; Male; Neonatal Screening; Phenylalanine; Phenylketonurias	2016
Behavioral and intellectual functioning in patients with tyrosinemia type I. Pediatric endocrinology, diabetes, and metabolism, 2012, Volume: 18, Issue:3 Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cognition Disorders; Female; Humans; Intelligence Tests; Male; Mental Disorders; Phenylalanine; Problem Solving; Tyrosine; Tyrosinemias; Wechsler Scales	2012
Timing is everything: executive functions in children exposed to elevated levels of phenylalanine. Neuropsychology, 2003, Volume: 17, Issue:3 Topics: Adolescent; Age of Onset; Attention; Attention Deficit Disorder with Hyperactivity; Brain; Case-Control Studies; Child; Cognition Disorders; Female; Humans; Male; Memory; Neuropsychological Tests; Phenylalanine; Phenylketonurias; Psychomotor Disorders; Time Factors; Verbal Learning	2003
Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression. Journal of abnormal child psychology, 2003, Volume: 31, Issue:6 Topics: Adult; Attention Deficit Disorder with Hyperactivity; Child; Female; Follow-Up Studies; Humans; Male; Mothers; Phenylalanine; Phenylketonurias; Pregnancy; Prospective Studies; Time Factors	2003
Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria. Journal of inherited metabolic disease, 2004, Volume: 27, Issue:2 Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Phenylalanine; Phenylketonurias; Prevalence; Retrospective Studies; Tyrosine	2004
Interhemispheric transfer in children with early-treated phenylketonuria. Journal of clinical and experimental neuropsychology, 1994, Volume: 16, Issue:3 Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Brain Damage, Chronic; Child; Corpus Callosum; Dominance, Cerebral; Female; Follow-Up Studies; Humans; Intelligence; Male; Nerve Fibers, Myelinated; Phenylalanine; Phenylketonurias; Psychomotor Performance; Reaction Time; Reference Values	1994
Deficits in selective and sustained attention processes in early treated children with phenylketonuria--result of impaired frontal lobe functions? European journal of pediatrics, 1996, Volume: 155, Issue:3 Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Female; Follow-Up Studies; Frontal Lobe; Humans; Infant; Infant, Newborn; Intelligence; Male; Mental Recall; Neuropsychological Tests; Phenylalanine; Phenylketonurias	1996
[Neurochemical and neurotransmitter studies in patients with learning disabilities]. No to hattatsu = Brain and development, 1999, Volume: 31, Issue:3 Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Humans; Intellectual Disability; Learning Disabilities; Methoxyhydroxyphenylglycol; Phenylalanine	1999
Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia, 2002, Volume: 40, Issue:1 Topics: Adolescent; Age Factors; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Child; Cognition Disorders; Female; Humans; Male; Phenylalanine; Phenylketonurias; Reaction Time; Regression Analysis; Task Performance and Analysis	2002
Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested. Report on medical guidelines & outcomes research, 2000, Feb-17, Volume: 11, Issue:4 Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Desipramine; Dextroamphetamine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Methylphenidate; Nicotine; Pemoline; Phenylalanine	2000
Phenylethylaminergic mechanisms in attention-deficit disorder. Biological psychiatry, 1991, Jan-01, Volume: 29, Issue:1 Topics: Attention Deficit Disorder with Hyperactivity; Child; Humans; Phenethylamines; Phenylacetates; Phenylalanine; Reference Values; Tyrosine	1991
Plasma amino acids in attention deficit disorder. Psychiatry research, 1990, Volume: 33, Issue:3 Topics: Amino Acids; Attention Deficit Disorder with Hyperactivity; Child; Female; Histidine; Humans; Isoleucine; Male; Phenylalanine; Tryptophan; Tyrosine	1990